RPRX
Royalty Pharma·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
RPRX fundamentals
Royalty Pharma (RPRX) released its earnings on Nov 5, 2025: revenue was 814.00M (YoY +44.15%), beat estimates; EPS was 0.51 (YoY -58.20%), missed estimates.
Revenue / YoY
814.00M
+44.15%
EPS / YoY
0.51
-58.20%
Report date
Nov 5, 2025
RPRX Earnings Call Summary for Q3,2025
- Revenue Growth: Q3 portfolio receipts up 11% to $814 million, with full-year guidance raised to $3.2 billion-$3.25 billion (14%-16% growth).
- Strategic Acquisitions: $1.26 billion invested in three high-impact deals (Imdelltra, Amvuttra, obexelimab) with low double-digit IRRs.
- Pipeline Expansion: 17 therapies in development, with six Phase III readouts expected in 2025-2026.
- Financial Strength: 81% cash flow margin, $9.2 billion investment-grade debt, and $1.5 billion returned to shareholders.
- China and Obesity Focus: Actively exploring synthetic royalty opportunities in China and obesity, with disciplined capital allocation.
EPS
Revenue
Revenue & Expenses
RPRX has released its 2025 Q3 earnings report, with revenue of 609.29M, reflecting a YoY change of 7.90%, and net profit of 444.21M, showing a YoY change of -44.91%. The Sankey diagram below clearly presents RPRX's revenue sources and cost distribution.
Key Indicators
Royalty Pharma (RPRX) key financial stats and ratios, covering profitability, financial health, and leverage.
Royalty Pharma (RPRX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Royalty Pharma (RPRX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Royalty Pharma (RPRX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Royalty Pharma (RPRX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Royalty Pharma (RPRX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Royalty Pharma's gross profit margin?Did Royalty Pharma beat or miss consensus estimates last quarter?What is the market's earnings forecast for Royalty Pharma next quarter?What were the key takeaways from Royalty Pharma's earnings call?What were the key takeaways from Royalty Pharma’s earnings call?What does Royalty Pharma do and what are its main business segments?What is Royalty Pharma's latest dividend and current dividend yield?What guidance did Royalty Pharma's management provide for the next earnings period?
